TINA’S WISH AND RISING STAR GRANTEE DR. SARAH HILL FEATURED IN IMPACT SUMMER 2020
“Almost 80% of women with ovarian cancer are diagnosed at an advanced stage, when there is a diminished chance for a cure,… View more
TINA’S WISH RESEARCHER DR. SAMUEL MOK RECOGNIZED IN TREATMENT BREAKTHROUGH
“Scientists have created a promising new way to treat late-stage ovarian and pancreatic cancers. The cancers are two of the most lethal… View more
TINA’S WISH AWARDS DANA-FARBER CANCER INSTITUTE WITH $200K GRANT IN SUPPORT OF EARLY DETECTION OVARIAN CANCER RESEARCH
Tina’s Wish awarded Dana-Farber Cancer Institute with a $200,000 grant in support of Dr. Dipanjan Chowdhury’s research, which is focused on developing… View more
TINA’S WISH RESEARCHER DR. SIMON GAYTHER PUBLISHES PAPER ON NEWLY IDENTIFIED GENES associated with an increased risk for ovarian cancer
“A team of researchers at UCLA’s Jonsson Comprehensive Cancer, Cedars-Sinai Cancer and Dana-Farber Cancer Institute have newly identified 34 genes that are… View more
DR. ALESSANDRO SANTIN PUBLISHES STUDY ON THE GENETIC CHARACTERISTICS OF OVARIAN TUMORS
“Yale Cancer Center researchers have defined the genetic characteristics of ovarian tumors, information that could lead to new opportunities for personalized therapy,… View more
DR. ANDREW GODWIN RECEIVES NATIONAL INSTITUTES OF HEALTH GRANT
“A team led by Andrew Godwin, PhD, deputy director of The University of Kansas Cancer Center and director of molecular oncology in… View more